MEDIFORD
LIVE

Serial Number

98330501

Owner

Mediford Corporation

Attorney

Matthew L. Frisbee

Filing Date

Dec 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MEDIFORD Trademark

Serial Number: 98330501 • Registration: 7790346

MEDIFORD is a trademark filed by Mediford Corporation on December 26, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Mediford Corporation

36-1 Shimizu-cho, Itabashi-ku
Tokyo 174-0053 , JP

Entity Type: 03

Trademark Details

Filing Date

December 26, 2023

Registration Date

May 13, 2025

Published for Opposition

March 25, 2025

Goods & Services

blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; testing and analyzing services of stool, urine and blood being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; clinical testing and analyzing of specimens, namely, blood, bodily fluids, tissues extracted from human and animals for medical diagnostic and treatment purposes provided by medical laboratories; testing and analyzing services of blood and stool for clinical testing for medical diagnostic and treatment purposes provided by medical laboratories; medical analysis of clinical data of clinical trials; medical diagnostic, testing and analyzing services for the diagnosis of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, oncological, urological and viral diseases and disorders, blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; medical diagnostic services for autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, oncological, urological and viral diseases and disorders, blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; provision of medical information; medical clinical testing and medical evaluation for autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, oncological, urological and viral diseases and disorders, blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; performing medical diagnosis of diseases based on evaluation of progress of clinical trials for autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, oncological, urological and viral diseases and disorders, blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; clinical testing, namely, medical testing services; clinical testing for use in medical treatment and medical examination services for human and animals; medical consultancy services relating to clinical tests; medical consultancy services relating to medical care; providing medical advice and information relating to clinical tests; medical and pharmaceutical consultation; medical analysis of clinical data of clinical trials

testing, inspection or research on pharmaceuticals, cosmetics, food additives or food including chemicals and agrochemicals for scientific research purposes; testing or research on prevention of pollution for scientific research purposes; testing of drinking water quality for scientific research purposes; environmental measurement and analysis for scientific research purposes; testing of microorganisms for scientific research purposes; environmental hygiene testing and other hygiene testing for scientific research purposes; immunological, biochemical, bacteriological or genetical analysis, testing, inspection or research relating to biological samples for scientific research purposes; analysis, testing, inspection or research relating to bacteriology, genetics or biotechnology for scientific research purposes; testing, inspection or research on agriculture, livestock breeding or fisheries for scientific research purposes; medical testing, inspection or research services for medical research purposes; scientific testing, research or laboratory services for scientific research purposes; providing scientific advice relating to scientific testing, research or laboratory services; scientific research in the nature of conducting clinical trials for others; medical research services, namely, conducting non-clinical trials relating to pharmaceuticals and medical devices; medical testing, inspection, research or development relating to treatment or prevention of diseases for medical research purposes; medical research services; blood testing for scientific research purposes; testing and analyzing services of stool, urine and blood for scientific research purposes; clinical testing and analyzing using specimens such as blood, bodily fluids, tissues extracted from human and animals for scientific research purposes; testing and analyzing services of blood and stool for clinical testing for scientific research purposes; management of clinical data of clinical trials, namely, planning and implementation project management of clinical trials

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 13, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 13, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 19, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Feb 27, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 4, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 10, 2024 GNFN
FINAL REFUSAL E-MAILED
Dec 10, 2024 GNFR
FINAL REFUSAL WRITTEN
Dec 10, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 31, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 24, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 8, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2024 NWOS
NEW APPLICATION ENTERED
Dec 26, 2023 NWAP